HP and neoplasm: Three weeks after injection, the weight and volume of the subcutaneous tumor in the Hp + sh-THBS2-BMSC-MVs + MGC-803 group were significantly decreased compared with those in the Hp + sh-NC-BMSC-MVs + MGC-803 group (P < 0.001, Fig. 6A-C).